MRK.DE 122.2 (-3.09%)
DE0006599905Drug ManufacturersDrug Manufacturers - Specialty & Generic

Merck (MRK.DE) Competitor Comparison

We are evaluating the key criteria listed to compare Merck (MRK.DE) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - MRK.DE ranking 0 / 54

These are the competitors of Merck in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Avadel Pharmaceuticals AVDL
642.17
2. Alvotech ALVO
146.83
3. Green Thumb Industries R9U2.F
73.37
4. ProPhase Labs PRPH
32.25
5. Catalent CTLT
20.24
6. Phibro Animal Health PAHC
17.45
7. Pacira BioSciences PCRX
16.43
8. Kamada KMDA
10.43
9. Neoleukin Therapeutics NLTX
8.58
10. Alimera Sciences ALIM
7.82
11. Vifor Pharma G2AB.F
7.23
12. Curaleaf Holdings CURLF
6.97
13. Organogenesis Holdings ORGO
6.81
14. PetIQ PETQ
6.43
15. Cumberland Pharmaceuticals CPIX
6.19
16. Zoetis ZTS
6.17
17. Linc LNC
5.92
18. Perrigo PRGO
5.63
19. Bausch Health Companies BHC
5.26
20. Elanco Animal Health ELAN
5.12
21. Kolinpharma KIP.MI
4.88
22. Amphastar Pharmaceuticals AMPH
3.85
23. Ayr Wellness 3KJB.F
3.71
24. Theratechnologies THTX
3.64
25. Taro Pharmaceutical Industries TARO
3.55
26. Ironwood Pharmaceuticals IRWD
3.34
27. Cronos Group CRON
3.18
28. Journey Medical DERM
3.07
29. Supernus Pharmaceuticals SUPN
3.02
30. Solid Biosciences SLDB
2.82
31. Procaps Group PROC
2.59
32. Collegium Pharmaceutical COLL
2.58
33. Zynerba Pharmaceuticals ZYNE
2.47
34. Embecta EMBC
2.4
35. Jupiter Wellness JUPW
2.39
36. Emergent BioSolutions EBS
2.38
37. Teva Pharmaceutical Industries TEVA
2.37
38. Societal CDMO SCTL
2.21
39. Eagle Pharmaceuticals EGRX
2.19
40. SCYNEXIS SCYX
2.15
41. Regencell Bioscience Holdings RGC
2.06
42. Relmada Therapeutics RLMD
2.06
43. ANI Pharmaceuticals ANIP
1.99
44. Clever Leaves Holdings CLVR
1.87
45. OptiNose OPTN
1.83
46. Alpha Teknova TKNO
1.8
47. Tilray Brands TLRY
1.8
48. Ascend Wellness Holdings AAWH
1.77
49. Biofrontera BFRI
1.74
50. Flora Growth FLGC
1.63
51. Universe Pharmaceuticals UPC
1.61
52. Evolus EOLS
1.33
53. Amneal Pharmaceuticals AMRX
0.9
54. Harrow Health HROW
0.48

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.